{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:07:02Z","timestamp":1785816422277,"version":"3.56.0"},"reference-count":129,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>Adipose tissue is unique in that it can undergo significant hypertrophy and atrophy, resulting in wide ranges of obesities and lipodystrophies. At the base of this elasticity is the lipid-filled adipocyte, which can either overfill by storing large amounts of triglycerides or shrink to a tiny cell by depleting its lipids and as such is remarkable in sustaining insults. As a major energy reservoir, the adipocyte may hold considerable calories necessary for survival and reproduction, two functions that are essential for the survival of the species. This review will summarize some of the recent studies that have advanced our understanding of the central and peripheral mechanisms that are initiated by adipocyte-secreted factors such as leptin, adiponectin, resistin, and retinol-binding protein 4. The intersection of obesity and lipodystrophy results in insulin resistance, which may be unlocked by elucidating the roles of these factors in pathways that control insulin sensitivity and glucose uptake.<\/jats:p>","DOI":"10.1210\/en.2007-1355","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T01:44:50Z","timestamp":1200620690000},"page":"925-934","source":"Crossref","is-referenced-by-count":39,"title":["Minireview: Obesity and LipOdystrophy\u2014Where Do the Circles Intersect?"],"prefix":"10.1210","volume":"149","author":[{"given":"Farid F.","family":"Chehab","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California 94107"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,1,17]]},"reference":[{"key":"2020071612161414200_R1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue.","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"2020071612161414200_R2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in human.","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"2020071612161414200_R3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng0398-213","article-title":"A leptin missense mutation associated with hypogonadism and morbid obesity.","volume":"18","author":"Strobel","year":"1998","journal-title":"Nat Genet"},{"key":"2020071612161414200_R4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.","volume":"392","author":"Clement","year":"1998","journal-title":"Nature"},{"key":"2020071612161414200_R5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0797-303","article-title":"Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene.","volume":"16","author":"Jackson","year":"1997","journal-title":"Nat Genet"},{"key":"2020071612161414200_R6","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/jc.2007-0687","article-title":"Hyperphagia and early onset obesity due to a novel homozygous missense mutation in prohormone convertase 1\/3.","volume":"92","author":"Farooqi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612161414200_R7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans.","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"key":"2020071612161414200_R8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2006.01.006","article-title":"POMC variant implicates \u03b2-melanocyte-stimulating hormone in the control of human energy balance.","volume":"3","author":"Lee","year":"2006","journal-title":"Cell Metab"},{"key":"2020071612161414200_R9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2006.01.007","article-title":"A role for \u03b2-melanocyte-stimulating hormone in human body-weight regulation.","volume":"3","author":"Biebermann","year":"2006","journal-title":"Cell Metab"},{"key":"2020071612161414200_R10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/en.2005-0812","article-title":"The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans.","volume":"47","author":"Yanik","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612161414200_R11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuron.2004.06.004","article-title":"Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.","volume":"42","author":"Balthasar","year":"2004","journal-title":"Neuron"},{"key":"2020071612161414200_R12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature06098","article-title":"Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.","volume":"449","author":"Parton","year":"2007","journal-title":"Nature"},{"key":"2020071612161414200_R13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.","volume":"106","author":"Vaisse","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.","volume":"348","author":"Farooqi","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/hmg\/ddg057","article-title":"Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.","volume":"12","author":"Yeo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"2020071612161414200_R16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nn1336","article-title":"A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.","volume":"7","author":"Yeo","year":"2004","journal-title":"Nat Neurosci"},{"key":"2020071612161414200_R17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn1073","article-title":"Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor.","volume":"6","author":"Xu","year":"2003","journal-title":"Nat Neurosci"},{"key":"2020071612161414200_R18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/mend.15.10.0706","article-title":"Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.","volume":"15","author":"Rios","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071612161414200_R19","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1101\/gad.8.19.2302","article-title":"The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.","volume":"8","author":"Ingraham","year":"1994","journal-title":"Genes Dev"},{"key":"2020071612161414200_R20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/endo.143.2.8652","article-title":"Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity.","volume":"143","author":"Majdic","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612161414200_R21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.12.021","article-title":"Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis.","volume":"49","author":"Dhillon","year":"2006","journal-title":"Neuron"},{"key":"2020071612161414200_R22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.275.5296.88","article-title":"Early onset of reproductive function in normal female mice treated with leptin.","volume":"275","author":"Chehab","year":"1997","journal-title":"Science"},{"key":"2020071612161414200_R23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ng0396-318","article-title":"Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin.","volume":"12","author":"Chehab","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612161414200_R24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","article-title":"Serotonin reciprocally regulates melanocortin neurons to modulate food intake.","volume":"51","author":"Heisler","year":"2006","journal-title":"Neuron"},{"key":"2020071612161414200_R25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1139\/y04-025","article-title":"Mutational analysis of the serotonin receptor 5HT2c in severe early-onset human obesity.","volume":"82","author":"Gibson","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"key":"2020071612161414200_R26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2006.10.033","article-title":"Deletion of the serotonin 2c receptor from transgenic mice overexpressing leptin does not affect their lipodystrophy but exacerbates their diet-induced obesity.","volume":"351","author":"Wang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612161414200_R27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ng0996-95","article-title":"Leptin activation of Stat3 in the hypothalamus of wild-type and ob\/ob mice but not db\/db mice.","volume":"14","author":"Vaisse","year":"1996","journal-title":"Nat Genet"},{"key":"2020071612161414200_R28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm1392","article-title":"Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake.","volume":"12","author":"Kitamura","year":"2006","journal-title":"Nat Med"},{"key":"2020071612161414200_R29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature"},{"key":"2020071612161414200_R30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2007.06.003","article-title":"Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.","volume":"6","author":"Kubota","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612161414200_R31","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1172\/JCI31516","article-title":"AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.","volume":"117","author":"Claret","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/oby.2004.89","article-title":"Melanin-concentrating hormone receptor mutations and human obesity: functional analysis.","volume":"12","author":"Gibson","year":"2004","journal-title":"Obes Res"},{"key":"2020071612161414200_R33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"AMP-activated protein kinase in metabolic control and insulin signaling.","volume":"100","author":"Towler","year":"2007","journal-title":"Circ Res"},{"key":"2020071612161414200_R34","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy.","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020071612161414200_R35","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","article-title":"LKB1 is the upstream kinase in the AMP-activated protein kinase cascade","volume":"13","author":"Woods","year":"2003","journal-title":"Curr Biol."},{"key":"2020071612161414200_R36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","article-title":"Complexes between the LKB1 tumor suppressor, STRAD \u03b1\/\u03b2 and MO25 \u03b1\/\u03b2 are upstream kinases in the AMP-activated protein kinase cascade.","volume":"2","author":"Hawley","year":"2003","journal-title":"J Biol"},{"key":"2020071612161414200_R37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-5793(95)01368-7","article-title":"5\u2032-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C\u03b1 and native bovine protein phosphatase-2AC.","volume":"377","author":"Davies","year":"1995","journal-title":"FEBS Lett"},{"key":"2020071612161414200_R38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","article-title":"Calmodulin-dependent protein kinase kinase-\u03b2 is an alternative upstream kinase for AMP-activated protein kinase.","volume":"2","author":"Hawley","year":"2005","journal-title":"Cell Metab"},{"key":"2020071612161414200_R39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","article-title":"Ca2+\/calmodulin-dependent protein kinase kinase-\u03b2 acts upstream of AMP-activated protein kinase in mammalian cells.","volume":"2","author":"Woods","year":"2005","journal-title":"Cell Metab"},{"key":"2020071612161414200_R40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab"},{"key":"2020071612161414200_R41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty acid oxidation by activation of AMP-activated protein kinase.","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"},{"key":"2020071612161414200_R42","first-page":"E1107","article-title":"AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle","volume":"273","author":"Merrill","year":"1997","journal-title":"Am J Physiol 1997"},{"key":"2020071612161414200_R43","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/diabetes.48.8.1667","article-title":"5\u2032 AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.","volume":"48","author":"Kurth-Kraczek","year":"1999","journal-title":"Diabetes"},{"key":"2020071612161414200_R44","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1152\/jappl.2001.91.3.1073","article-title":"Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase.","volume":"91","author":"Zheng","year":"2001","journal-title":"J Appl Physiol"},{"key":"2020071612161414200_R45","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1242\/jcs.115.11.2433","article-title":"Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK).","volume":"115","author":"Barnes","year":"2002","journal-title":"J Cell Sci"},{"key":"2020071612161414200_R46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action.","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R47","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1152\/ajpendo.00453.2005","article-title":"Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues","volume":"291","author":"LeBrasseur","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612161414200_R48","first-page":"9073","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin.","volume":"278","author":"Pajvani","year":"2003","journal-title":"Implications for metabolic regulation and bioactivity, J Biol Chem"},{"key":"2020071612161414200_R49","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071612161414200_R50","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071612161414200_R51","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"2020071612161414200_R52","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI31021","article-title":"Obesity-associated improvements in metabolic profile through expansion of adipose tissue.","volume":"117","author":"Kim","year":"2007","journal-title":"Clin Invest"},{"key":"2020071612161414200_R53","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1074\/jbc.M700098200","article-title":"Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1.","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071612161414200_R54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes.","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2020071612161414200_R55","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin\/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-\u03b3 action in humans.","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"2020071612161414200_R56","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1210\/jcem.87.5.8627","article-title":"Increased resistin gene and protein expression in human abdominal adipose tissue.","volume":"87","author":"McTernan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612161414200_R57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR\u03b3 activators.","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612161414200_R58","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2337\/db05-0615","article-title":"Loss of resistin improves glucose homeostasis in leptin deficiency.","volume":"55","author":"Qi","year":"2006","journal-title":"Diabetes"},{"key":"2020071612161414200_R59","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin.","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"2020071612161414200_R60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/oby.2003.137","article-title":"Correlation between serum resistin level and adiposity in obese individuals.","volume":"11","author":"Azuma","year":"2003","journal-title":"Obes Res"},{"key":"2020071612161414200_R61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.","volume":"149","author":"Silha","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2020071612161414200_R62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans.","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"2020071612161414200_R63","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612161414200_R64","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diabetes.53.5.1279","article-title":"High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.","volume":"53","author":"Vozarova de Courten","year":"2004","journal-title":"Diabetes"},{"key":"2020071612161414200_R65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00592-005-0187-x","article-title":"Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.","volume":"42","author":"Hasegawa","year":"2005","journal-title":"Acta Diabetol"},{"key":"2020071612161414200_R66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000084871","article-title":"Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with \u03b1-melanostimulating hormone.","volume":"81","author":"Wilkinson","year":"2005","journal-title":"Neuroendocrinology"},{"key":"2020071612161414200_R67","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1172\/JCI30440","article-title":"Hypothalamic resistin induces hepatic insulin resistance.","volume":"117","author":"Muse","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes.","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"2020071612161414200_R69","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R70","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMc061863","article-title":"Retinol-binding protein 4 and insulin resistance.","volume":"355","author":"Takashima","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R71","first-page":"1393","article-title":"Retinol-binding protein 4 and insulin resistance.","volume":"355","author":"Erikstrup","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R72","first-page":"1394","article-title":"Retinol-binding protein 4 and insulin resistance.","volume":"355","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R73","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2337\/db06-0616","article-title":"Retinol-binding protein 4 in human obesity.","volume":"55","author":"Janke","year":"2006","journal-title":"Diabetes"},{"key":"2020071612161414200_R74","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-006-0557-0","article-title":"Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.","volume":"50","author":"Graham","year":"2007","journal-title":"Diabetologia"},{"key":"2020071612161414200_R75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/372182a0","article-title":"Insulin and growth retardation in mice lacking insulin receptor substrate-1.","volume":"372","author":"Tamemoto","year":"1994","journal-title":"Nature"},{"key":"2020071612161414200_R76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/372186a0","article-title":"Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.","volume":"372","author":"Araki","year":"1994","journal-title":"Nature"},{"key":"2020071612161414200_R77","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","article-title":"Disruption of IRS-2 causes type 2 diabetes in mice.","volume":"391","author":"Withers","year":"1998","journal-title":"Nature"},{"key":"2020071612161414200_R78","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1101\/gad.1034802","article-title":"Lipoatrophic diabetes in Irs1(\u2212\/\u2212)\/Irs3(\u2212\/\u2212) double knockout mice.","volume":"16","author":"Laustsen","year":"2002","journal-title":"Genes Dev"},{"key":"2020071612161414200_R79","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/diabetes.51.8.2369","article-title":"Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes.","volume":"51","author":"Dietze","year":"2002","journal-title":"Diabetes"},{"key":"2020071612161414200_R80","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1096\/fj.02-0158rev","article-title":"Analysis of paradoxical observations on the association between leptin and insulin resistance.","volume":"16","author":"Ceddia","year":"2002","journal-title":"FASEB J"},{"key":"2020071612161414200_R81","doi-asserted-by":"crossref","first-page":"25157","DOI":"10.1074\/jbc.M402477200","article-title":"Protein kinase C-\u03b6-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1.","volume":"279","author":"Moeschel","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071612161414200_R82","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1096\/fj.05-4635fje","article-title":"Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1.","volume":"20","author":"Hennige","year":"2006","journal-title":"FASEB J"},{"key":"2020071612161414200_R83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00125-005-0060-z","article-title":"Regulation of insulin signaling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin.","volume":"49","author":"Palanivel","year":"2006","journal-title":"Diabetologia"},{"key":"2020071612161414200_R84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.07-8173com","article-title":"Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1\/2 in primary human adipocytes.","volume":"21","author":"Ost","year":"2007","journal-title":"FASEB J"},{"key":"2020071612161414200_R85","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cell.2007.03.053","article-title":"A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis.","volume":"129","author":"Nachury","year":"2007","journal-title":"Cell"},{"key":"2020071612161414200_R86","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors.","volume":"275","author":"Dowell","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071612161414200_R87","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy.","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"key":"2020071612161414200_R88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation, and death.","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2020071612161414200_R89","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-\u03b3 gene in a patient with familial partial lipodystrophy.","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612161414200_R90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"2020071612161414200_R91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0163-7827(03)00051-1","article-title":"Enzymes of triacylglycerol synthesis and their regulation.","volume":"43","author":"Coleman","year":"2004","journal-title":"Prog Lipid Res"},{"key":"2020071612161414200_R92","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.M500553-JLR200","article-title":"Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity.","volume":"47","author":"Vergnes","year":"2006","journal-title":"J Lipid Res"},{"key":"2020071612161414200_R93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"key":"2020071612161414200_R94","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.","volume":"36","author":"Windpassinger","year":"2004","journal-title":"Nat Genet"},{"key":"2020071612161414200_R95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071612161414200_R96","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy.","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2020071612161414200_R97","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat Genet"},{"key":"2020071612161414200_R98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","article-title":"Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).","volume":"9","author":"Muchir","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071612161414200_R99","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nrg1906","article-title":"Human laminopathies: nuclei gone genetically awry.","volume":"7","author":"Capell","year":"2006","journal-title":"Nat Rev Genet"},{"key":"2020071612161414200_R100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance.","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab"},{"key":"2020071612161414200_R101","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR\u03b32: tissue-specific regulator of an adipocyte enhancer.","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev"},{"key":"2020071612161414200_R102","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"2020071612161414200_R103","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0004.2006.00674.x","article-title":"A frameshift mutation in peroxisome-proliferator-activated receptor-\u03b3 in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).","volume":"70","author":"Hegele","year":"2006","journal-title":"Clin Genet"},{"key":"2020071612161414200_R104","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-\u03b3.","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"2020071612161414200_R105","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream.","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"2020071612161414200_R106","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2.","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"2020071612161414200_R107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB \u03b2.","volume":"112","author":"Garofalo","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R108","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse.","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev"},{"key":"2020071612161414200_R109","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev"},{"key":"2020071612161414200_R110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"2020071612161414200_R111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R112","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.","volume":"50","author":"Ebihara","year":"2001","journal-title":"Diabetes"},{"key":"2020071612161414200_R113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/83685","article-title":"Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin.","volume":"27","author":"Peterfy","year":"2001","journal-title":"Nat Genet"},{"key":"2020071612161414200_R114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2004.12.002","article-title":"Lipin, a lipodystrophy and obesity gene.","volume":"1","author":"Phan","year":"2005","journal-title":"Cell Metab"},{"key":"2020071612161414200_R115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M600272-JLR200","article-title":"A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression.","volume":"48","author":"Harmelen","year":"2007","journal-title":"J Lipid Res"},{"key":"2020071612161414200_R116","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.2337\/db05-1688","article-title":"Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor \u03b3 activation.","volume":"55","author":"Yao-Borengasser","year":"2006","journal-title":"Diabetes"},{"key":"2020071612161414200_R117","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1\u03b1\/PPAR\u03b1 regulatory pathway.","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metab"},{"key":"2020071612161414200_R118","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm1262","article-title":"Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy.","volume":"11","author":"Pajvani","year":"2005","journal-title":"Nat Med"},{"key":"2020071612161414200_R119","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/endo.142.1.7909","article-title":"Transgenic mice overexpressing leptin accumulate adipose mass at an older, but not younger, age.","volume":"42","author":"Qiu","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612161414200_R120","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2337\/diabetes.48.9.1822","article-title":"Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.","volume":"48","author":"Ogawa","year":"1999","journal-title":"Diabetes"},{"key":"2020071612161414200_R121","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"2020071612161414200_R122","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R123","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunning-type familial partial lipodystrophy.","volume":"56","author":"Park","year":"2007","journal-title":"Metabolism"},{"key":"2020071612161414200_R124","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea.","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071612161414200_R125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","article-title":"Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.","volume":"113","author":"Asilmaz","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071612161414200_R126","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/en.2003-0870","article-title":"Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome.","volume":"144","author":"Unger","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612161414200_R127","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature"},{"key":"2020071612161414200_R128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0196-9781(96)00025-3","article-title":"Leptin enters the brain by a saturable system independent of insulin.","volume":"17","author":"Banks","year":"1996","journal-title":"Peptides"},{"key":"2020071612161414200_R129","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1073\/pnas.94.16.8878","article-title":"Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.","volume":"94","author":"Halaas","year":"1997","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/3\/925\/8996266\/endo0925.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/3\/925\/8996266\/endo0925.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:06:35Z","timestamp":1630541195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/3\/925\/2454933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,17]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-1355","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,17]]}}}